Vikas Chandrawanshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vikas Chandrawanshi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Sarika Mehra
Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, India
4 shared publications Kamal Prashad Segar
Department of Chemical Engineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India
2 shared publicationsAishwarya Ramakrishnan
Department of Biosciences and Bioengineering , Indian Institute of Technology Bombay , Mumbai , India 400076
1 shared publicationAmbuja Navalkar
Department of Biosciences and Bioengineering , Indian Institute of Technology Bombay , Mumbai , India 400076
1 shared publicationBasil Alias
Department of Biosciences and Bioengineering , Indian Institute of Technology Bombay , Mumbai , India 400076
1 shared publicationDhiman Ghosh
Department of Biosciences and Bioengineering , Indian Institute of Technology Bombay , Mumbai , India 400076
1 shared publication
Latest Publications
- 20 July 2018
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 57 (33) , 5014-5028
The Familial α-Synuclein A53E Mutation Enhances Cell Death in Response to Environmental Toxins Due to a Larger Population of Oligomers
Amyloid formation of α-synuclein (α-Syn) and its familial mutations are directly linked with Parkinson’s disease (PD) pathogenesis. Recently, a new familial α-Syn mutation (A53E) was discovered, associated with an early onset aggressive form of PD, which delays α-Syn aggregation. When we overexpressed wild-type (WT) and A53E proteins in cells, showed neither toxicity nor aggregate formation, suggesting merely overexpression may not recapitulate the PD phenotype in cell models. We hypothesized that cells expressing the A53E mutant might possess enhanced susceptibility to PD-associated toxicants compared to that of the WT. When cells were treated with PD toxicants (dopamine and rotenone), cells expressing A53E showed more susceptibility to cell death along with compromised mitochondrial potential and an increased production of reactive oxygen species. The higher toxicity of A53E could be due to more oligomers being formed in cells as confirmed by a dot blot assay using amyloid specific OC and A11 antibody and using an in vitro aggregation study. The cellular model presented here suggests that along with familial mutation, environmental and other cellular factors might play a crucial role in dictating PD pathogenesis.
- 20 July 2018
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 57 (33) , 5014-5028
The Familial α-Synuclein A53E Mutation Enhances Cell Death in Response to Environmental Toxins Due to a Larger Population of Oligomers
Amyloid formation of α-synuclein (α-Syn) and its familial mutations are directly linked with Parkinson’s disease (PD) pathogenesis. Recently, a new familial α-Syn mutation (A53E) was discovered, associated with an early onset aggressive form of PD, which delays α-Syn aggregation. When we overexpressed wild-type (WT) and A53E proteins in cells, showed neither toxicity nor aggregate formation, suggesting merely overexpression may not recapitulate the PD phenotype in cell models. We hypothesized that cells expressing the A53E mutant might possess enhanced susceptibility to PD-associated toxicants compared to that of the WT. When cells were treated with PD toxicants (dopamine and rotenone), cells expressing A53E showed more susceptibility to cell death along with compromised mitochondrial potential and an increased production of reactive oxygen species. The higher toxicity of A53E could be due to more oligomers being formed in cells as confirmed by a dot blot assay using amyloid specific OC and A11 antibody and using an in vitro aggregation study. The cellular model presented here suggests that along with familial mutation, environmental and other cellular factors might play a crucial role in dictating PD pathogenesis.
- 13 January 2017
- Published by Wiley
- p. 417-468
Advanced Bioprocess Engineering: Fed‐Batch and Perfusion Processes
- 13 January 2017
- Published by Wiley
- p. 417-468
Advanced Bioprocess Engineering: Fed‐Batch and Perfusion Processes
- Open Access
- 4 December 2013
- Published by Springer Nature in BMC Proceedings
- Vol. 7 (S6) , P67
Systems biology of unfolded protein response in recombinant CHO cells
- 4 December 2013
- Published by Springer Nature in BMC Proceedings
- Vol. 7 (S6) , P67
Open AccessSystems biology of unfolded protein response in recombinant CHO cells